Speaking at the inaugural session of 15th BioAsia Summit, Rao, popularly known as KTR, said the state has further strengthened its leadership position in life sciences innovation and manufacturing hubs by contributing more than 35 per cent to the national pharmaceutical production of the country.
He said Telangana has become a vaccine hub of the country and the world by producing about 33 per cent of global vaccines dosages and significantly contributing to elimination of global pain and disease.
The Genome Valley Cluster here is among the largest life sciences clusters in Asia and the government will continue to support the cluster to strengthen its dominant position, he said.
From humble beginnings in the year 1999, the cluster has grown tremendously to become home to more than 200 companies with approximately 10,000 scientific and technical workforces today, with global majors like Novartis, GSK, Sanofi, Ferring Pharma, Chemo, DuPont, Ashland and US Pharmacopeia among others, the minister added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
